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The interleukin 2 receptor a-chain (IL-2Ra) gene is a key regulator of lymphocyte proliferation. IL-2Ra is
rapidly and potently induced in T cells in response to mitogenic stimuli. Interleukin 2 (IL-2) stimulates IL-2Ra
transcription, thereby amplifying expression of its own high-affinity receptor. IL-2Ra transcription is at least
in part controlled by two positive regulatory regions, PRRI and PRRII. PRRI is an inducible proximal
enhancer, located between nucleotides 2276 and 2244, which contains NF-kB and SRE/CArG motifs. PRRII
is a T-cell-specific enhancer, located between nucleotides 2137 and 264, which binds the T-cell-specific Ets
protein Elf-1 and HMG-I(Y) proteins. However, none of these proximal regions account for the induction of
IL-2Ra transcription by IL-2. To find new regulatory regions of the IL-2Ra gene, 8.5 kb of the 5* end noncoding
sequence of the IL-2Ra gene have been sequenced. We identified an 86-nucleotide fragment that is 90%
identical to the recently characterized murine IL-2-responsive element (mIL-2rE). This putative human
IL-2rE, designated PRRIII, confers IL-2 responsiveness on a heterologous promoter. PRRIII contains a Stat
protein binding site that overlaps with an EBS motif (GASd/EBSd). These are essential for IL-2 inducibility
of PRRIII/CAT reporter constructs. IL-2 induced the binding of Stat5a and b proteins to the human GASd
element. To confirm the physiological relevance of these findings, we carried out in vivo footprinting experi-
ments which showed that stimulation of IL-2Ra expression correlated with occupancy of the GASd element.
Our data demonstrate a major role of the GASd/EBSd element in IL-2Ra regulation and suggest that the
T-cell-specific Elf-1 factor can serve as a transcriptional repressor.
Interleukin-2 (IL-2), a key regulator of the immune re-
sponse, is secreted by activated T cells upon antigenic stimu-
lation. Binding of IL-2 to its high-affinity receptor induces
proliferation as well as functional differentiation of T and B
lymphocytes and natural killer activation (63, 68, 69, 74). The
high-affinity IL-2 receptor (IL-2R) consists of three chains:
IL-2Ra, IL-2Rbc, and IL-2Rgc (7, 35, 67, 71). The two latter
subunits are shared by other cytokine receptors: IL-2Rbc is
part of the IL-15R (16), and IL-2Rgc is part of IL-4R, IL-7R,
IL-9R, and IL-15R (31, 48, 59). IL-2Rbc and IL-2Rgc are
present constitutively on resting T lymphocytes (reviewed in
reference 42). In contrast, the a chain of IL-2R appears at the
cell surface only after activation (reviewed in reference 34).
Expression of the human IL-2Ra gene is regulated by two
positive regulatory regions within its proximal enhancer/pro-
moter region, located between nucleotides 2276 and 2244
and between nucleotides2137 and264, designated PRRI and
PRRII, respectively, by John et al. (26). PRRI contains kB and
SRE/CArG box regulatory elements and is required for acti-
vation of IL-2Ra expression by Tax (transcription activator
protein of human T-cell leukemia virus type 1) as well as by
stimulation with phorbol myristate acetate and IL-1. Transient
transfection experiments have suggested that NF-kB and an
SRE-related protein control the activity of PRRI (33, 36, 52).
We have recently provided strong evidence for a major role of
these sites by in vivo genomic footprinting (1). PRRII contains
binding sites for an Ets family protein, Elf-1, and the nonhis-
tone chromatin-associated protein, HMG-I(Y), and is involved
in basal promoter activity and T-cell specificity of IL-2Ra ex-
pression (26).
Binding of IL-2 to its receptor induces activation of cyto-
plasmic tyrosine kinases belonging to the Janus kinase (Jak)
family (58). To date, the Jak family consists of Jak1, Jak2, Jak3,
and Tyk2 (13, 21, 32, 79). Cytokine receptor subunits selec-
tively associate with one Jak kinase (reviewed in references 24
and 60). The IL-2Rgc chain is associated with Jak3, and IL-
2Rbc is associated with Jak1 (27, 28, 43, 80). Downstream
effectors of the Jak kinases are the signal transducers and
activators of transcription (Stat proteins). This family of pro-
teins at present includes seven mammalian members: Stat1,
2, 3, 4, 5a, 5b, and 6 (38, 56, 72, 82, 83). Stat5 proteins
are activated by IL-2, IL-3, IL-7, IL-9 (29), IL-15, erythropoi-
etin (10), and prolactin (19, 37, 44, 72). Activation of Jak
kinases following ligand-mediated oligomerization leads to ty-
rosine phosphorylation of Stat proteins. Phosphorylated Stat
proteins dimerize via their SH2 domains (62). Dimers can
enter the nucleus and bind to specific DNA sequences (re-
viewed in references 22, 24, and 60). The transcriptional activ-
ity of Stat complexes including Stat5 is controlled by both
tyrosine and serine phosphorylation (5, 78). IL-2 stimulation of
T or NK cells results in activation of Stat3 and Stat5 (6, 15, 37,
73).
It has previously been shown that IL-2 stimulates IL-2Ra
transcription, thereby amplifying expression of its own high-
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affinity receptor (11, 39, 54). More recently, the physiological
relevance of the positive regulation of IL-2Ra gene transcrip-
tion by IL-2 has been demonstrated in both humans (53) and
mice (64). In transgenic mice, the role of the 59 flanking region
of the IL-2Ra gene for this regulation has been demonstrated
(64), and an IL-2-responsive enhancer (IL-2rE) has been iden-
tified in the murine IL-2Ra gene. This 78-nucleotide segment
maps 1.3 kb upstream of the major transcription site and con-
tains two potential binding sites for Stat family proteins (GAS
motif) and a potential Ets-binding site (EBS) (65). Using nu-
cleotide sequence analysis, we have identified an 876-nucleo-
tide segment in the 59 flanking region of the human IL-2Ra
gene that is 66% identical with the region between nucleotides
2900 and21700 in the murine gene. It includes a stretch of 86
nucleotides which is 90% identical to the murine IL-2rE. By
transient transfection experiments we show that this putative
human IL-2rE, here designated PRRIII, confers IL-2 respon-
siveness on a heterologous promoter. PRRIII contains two
Stat binding sites, one GATA site, and two EBS motifs. We
have identified the constitutive and inducible factors which
bind to IL-2rE cis-acting elements by electrophoretic mobility
shift assays (EMSAs) and DNA affinity purification. Point mu-
tations and in vivo footprinting analysis revealed a major role
of the distal Stat-binding site which overlaps with an EBS
motif. PRRIII and its mouse homolog are the first clearly
identified natural IL-2 responsive enhancers, and the func-
tional characterization of PRRIII presented here contributes
to the elucidation of IL-2-stimulated transcription in general
and significantly improves our understanding of the transcrip-
tional regulation of the IL-2Ra gene. It thereby opens new
perspectives for the comprehension of the role of IL-2Ra
expression in immune responses.
(This paper partially fulfills the requirements for the doc-
toral degrees of P. Le´cine and P. Rameil.)
MATERIALS AND METHODS
Cell culture. The IL-2-dependent human T-cell line Kit225 (18) was main-
tained in RPMI 1650 with 10% fetal calf serum containing 2 mM L-glutamine and
1 nM recombinant IL-2 (Eurocetus). The cells were arrested in a quiescent state
by washing them twice in phosphate-buffered saline (PBS) and culturing in
RPMI 1650 with 10% fetal calf serum in the absence of IL-2 for 20 h (for
transient transfection experiments) or for 48 h (for EMSA and affinity purifica-
tion of DNA binding proteins). Ba/F3, a murine proB cell line, was grown in
RPMI 1650 with 10% fetal calf serum containing 2 mM L-glutamine and murine
IL-3. Murine IL-3 was obtained as a supernatant of COS-1 cells transiently
transfected with a plasmid containing the murine IL-3 cDNA (a generous gift of
F. Lee, DNAX). Human peripheral blood mononuclear cells (PBMC) were
isolated from voluntary, healthy blood donors and maintained for 3 days with 2.5
mg of phytohemagglutinin (Sigma) per ml in RPMI 1650 with 10% fetal calf
serum containing 2 mM L-glutamine. PBMC were arrested in a quiescent state by
two washes in PBS and cultured in RPMI 1650 with 10% fetal calf serum in the
absence of IL-2 for 20 h before stimulation with 50 U of recombinant IL-2 per
ml as indicated in figure legends.
EMSAs, affinity purification of DNA binding proteins, and Western blots
(immunoblots).Whole-cell extracts were prepared by lysis of 43 107 cells per ml
for 20 min at 408C in lysis buffer (50 mM Tris-HCl [pH 8.0], 0.5% Nonidet P-40,
150 mMNaCl, 10% glycerol, 0.1 mM EDTA, 10 mMNaF, 1 mMNa3VO3, 1 mM
phenyl methylsulfonyl fluoride, 1 mM dithiothreitol, 1 mg of aprotinin per ml, 1
mg of leupeptin per ml, 1 mg of chymostatin per ml). Cell extracts were pre-
cleared by centrifugation at 13,000 rpm for 5 min at 48C. Synthetic oligonucle-
otide probes were end labeled with [g-32P]ATP. The following probes were used
(GAS motifs are underlined; EBS and GATA motifs are doubly underlined; the
mutated nucleotides are in boldface): FcgRI-GAS, GTATTTCCCAGAAAAG
GAAC; FcgRI-mGAS, GTATTGACCAGAAAAGGAAC; IL-2Ra-GASd/
EBSd, TTTCTTCTAGGAAGTACC; IL-2Ra-m1GASd, TTTCTGATAGGAA
GTACC; IL-2Ra-m2GASd, TTTCGGCTAGGAAGTACC; IL-2Ra-mEBSd,
TTTCTTCTCCGAAGTACC; IL-2Ra-GASp/GATA, ACATTTCTGATAATAG
AATT; EBSa, GATAACAGGAAGTGGTTGTA; EBSz, GATAAACACCAAGT
GGTTGTA.
To reveal GAS-binding proteins, 8 ml of whole-cell extracts, equivalent to 3 3
105 cells, was incubated for 10 min at room temperature in the presence of 1.2
ml of poly(dI-dC) (1 mg/ml in H2O); 5 3 104 cpm of labeled probe (approxi-
mately 1 ng) was then added, and the binding reaction was allowed to proceed for
an additional 15 min at room temperature in a final volume of 20 ml containing
10 mMHEPES (N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic acid) (pH 7.9),
1.5 mM MgCl2, 0.1 mM EGTA [ethylene glycol-bis(b-aminoethyl ether)-N-N-
N9-N9-tetraacetic acid], 5% glycerol, 1 mg of bovine serum albumin per ml, 0.25
mg of tRNA per ml, and 2% Ficoll. Complexes were separated on 5% nonde-
naturing polyacrylamide gels in 0.53 TBE and detected by autoradiography. For
competition experiments, unlabeled oligonucleotides were preincubated with cell
extracts for 10 min at room temperature prior to addition of the probe.
Supershift assays of GAS-binding proteins were performed by incubating the
extracts 30 min at room temperature with either anti-MGF/Stat5a (17) or anti-
Stat5 C-17, directed against amino acids 711 to 727 of murine Stat5b (Santa Cruz
Biotechnology). Anti-Stat5 C-17 recognizes both Stat5a and Stat5b proteins
including their alternatively spliced forms or anti-Stat3 (UBI) before the addition
of 32P-labeled probe. Supershift experiments of EBS binding proteins were
performed by incubating the binding reactions with either anti-Elf-1 or anti-Ets-
1/Ets-2 (Santa Cruz Biotechnology) or with anti-Ets1/2 #8, anti-Fli-1 #61, or
anti-Tel #69 (2, 55) before the addition of 32P-labeled probe. DNA binding
proteins were isolated from whole-cell extracts from 2 3 107 cells, precleared for
15 min at 48C with insolubilized protein A (Sigma), by incubation with 2 mg of
59-biotinylated oligonucleotides for 1 h at 48C as described (4). In competition
experiments, nonbiotinylated oligonucleotides were added 30 min at 48C before
addition of biotinylated oligonucleotides. Complexes were washed twice in lysis
buffer, eluted in sample buffer, separated by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE), and transferred to polyvinylene difluo-
ride membranes. Bound proteins were detected by Western blot analysis using
the Stat5a- and Stat5b-specific antisera purchased from R&D Systems and the
anti-Elf-1 from Santa Cruz Biotechnology.
Plasmids and mutagenesis. A genomic 8.5-kb EcoRI fragment containing the
59-end noncoding sequence of the human IL-2Ra gene was subcloned from the
Charon 4A phage clone A39 (23) into pUC18. The complete sequence was
determined by shotgun and oligo-primed gene walking and will be published
elsewhere (33a). The different fragments of DNA (Fig. 1A) were subcloned into
the pTK4-CAT. This vector was derived (41) by inserting the multiple cloning
site of pSP73 (Promega) into NdeI- and HindIII-digested pTK3-CAT. pTK4-
CAT/963 (59339) contains the PvuII/SphI fragment of IL-2Ra genomic DNA.
pTK4-CAT/250 (59339) and pTK4-CAT/250 (39359) contain the 250-nucleotide
XbaI fragment of the IL-2Ra 59 flanking region in alternative orientations.
pCMV-CAT has been described previously (14), and GRR3 was obtained from
D. Cantrell. Expression vectors for MGF/Stat5a (pXM/Stat5a) and mStat5b
(pXM/Stat5b) were obtained from F. Gouilleux (38, 72), for Elf-1 from J. M.
Leiden (70), and for Ets-1 from J. Ghysdael. Mutagenesis was performed with a
Transformer Site-Directed Mutagenesis Kit (Clontech) and pUC19 according to
the manufacturer’s instructions. The oligonucleotide primers used to disrupt the
GASd and EBSd motifs were mGASd (CCGCTGTTCTGAGCAGTTTC
GGCTAGGAAGTACC) and mEBSd (CTGTTCTGAGCAGTTTCTTCTCCG
AAGTACCAAAC). The choice for the underlined nucleotide substitutions was
based on previous studies in which either factor binding or functional activity of
the particular binding site was destroyed (5, 77).
Transient transfections and CAT assays. IL-2-starved Kit225 cells (1.5 3 107)
were electrotransfected in a BioRad Gene Pulser (330 V, 9505F) with 25 mg of
IL-2Ra enhancer constructs or 10 mg of pCMV-CAT and GRR3-CAT plasmids.
Amounts of expression vectors used in transfections are indicated in figure
legends. Following transfection, half of the cells were maintained for 12 to 16 h
in RPMI 1650 with 10% fetal calf serum in the absence of IL-2 and half were
maintained in the presence of 20 nM IL-2. Cell lysis and chloramphenicol
acetyltransferase (CAT) assays were performed with the CAT enzyme-linked
immunosorbent assay kit (Boehringer Mannheim) according to the manufactur-
er’s instructions with 50 mg of cell extracts.
In vivo footprint analysis. Genomic footprint analyses were performed as
previously described (1) by the dimethyl sulfate (DMS)/ligation-mediated PCR
(LM-PCR) method with in vitro and in vivo methylated genomic DNA purified
from Kit225 and primary human T cells. The following oligonucleotide primers
were used for the coding strand: primer 1, GGAACAAGTTCAAGAAAGG
AAC ([24043, 24064], Tm 598C); primer 2, TAACTAGGTCATCCAGGACA
GCCG ([24078, 24102], Tm 638C); primer 3, CATCCAGGACAGCCGGTCA
ACAGTGCAAG ([24088, 24116], Tm 688C). For the noncoding strand, we
used primer 4, TCACCCCACTGTACGTCTA ([24175, 24157], Tm 608C);
primer 5, AGTGGTCTTAAACCTAAGGGAAGGC ([24249, 24225], Tm
638C); and primer 6, CCTAAGGGAAGGCAGTCTAGGTCAG ([24237,
24213], Tm 688C). At least three independent experiments were performed to
analyze each strand of the PPRIII in both Kit225 and primary human T cells.
RESULTS
A fragment of the human IL-2Ra gene 5* flanking region is
highly homologous to the mouse IL-2Ra IL-2rE. The prox-
imal enhancer/promoter region of the human IL-2Ra gene
characterized to date does not fully account for the cell type
specificity and the activation-dependent regulation of human
IL-2Ra gene transcription (8, 26, and our unpublished obser-
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vations). The sequence of its 59 flanking region has only been
reported up to nucleotide position 21422 relative to the major
transcription initiation site (76). To further investigate the
organization of the human IL-2Ra chain locus, the nucleotide
sequence of the 59 flanking region was determined up to po-
sition 29365 bp (EMBL accession number, Z70243) (33a).
Computer searches revealed that, apart from the already re-
ported proximal segment (66), two other conserved regions are
shared by human and murine IL-2Ra 59-flanking regions (Fig.
1A). The first is a short fragment of 222 nucleotides (position
22297 to 22084 in humans and 2818 to 2602 in mice) with
60% identity. The second fragment encompasses 876 nucleo-
tides (position 24522 to 23676 in humans and 21726 to 2894
in mice) and displays 66% identity between the two species. It
contains a core sequence of 86 nucleotides that shows 90%
identity and corresponds to the recently identified mouse IL-
2-responsive C3 region (65). The alignment between this por-
tion (position 24199 to 24114) of the human gene and the
mouse IL-2rE (position 21383 to 21299) is shown in Fig. 1B.
Four out of five putative regulatory elements present in the
human gene are conserved in the mouse: two GAS sites, GASd
[TTC(N)3GAA] and GASp [TT(N)5AA] (61), a GATA site
(WGATAR) (30) which overlaps with GASp and the proximal
EBS consensus site (AGGAA) (51). Analysis of the mouse
gene has shown that these sites are required for IL-2rE func-
tion (65). Interestingly, the distal human GAS element
(GASd) overlaps with another EBS motif (EBSd). In the
mouse sequence, the EBSd is disrupted by an inversion
(ANG) (Fig. 1B).
Identification of PRRIII, a new positive regulatory region in
the human IL-2Ra gene. We screened the human IL-2Ra
59-flanking region for regulatory elements, upstream of PRRI
FIG. 1. Schematic representation of the 59-flanking region of the human IL-2Ra gene. (A) Restriction map of the genomic 8.5-kb EcoRI fragment containing the
59 end noncoding sequence of the human IL-2Ra gene. The portion previously reported from position 21242 to 1251 (8) is represented by a striped arrow. Nucleotide
numbers refer to the major site of transcription initiation (11). The PvuII/SphI fragment (position 24473 to 23510, 963 nucleotides) and the XbaI fragment (position
24260 to24010, 250 nucleotides) are indicated by two open boxes. The regions conserved in the mouse IL-2Ra gene are indicated by three lines at the bottom of panel
A. (B) Partial sequence comparison of the distal region conserved between the human and mouse IL-2Ra genes. The mouse sequence corresponds to the murine IL-2rE
C3 fragment (65). The consensus binding sites for known transcription factors are in boldface. The putative GAS elements are underlined (single line), and the putative
EBS and GATA elements are double underlined. The suffixes d and p indicate distal and proximal elements within the conserved core region.
VOL. 16, 1996 Jak-Stat ACTIVATION OF IL-2Ra GENE 6831
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and PRRII, by transient transfection assays. For this purpose,
a series of fragments derived from the 8.5-kb fragment be-
tween nucleotides 29365 and 21238 were inserted upstream
of the minimal promoter of the herpes simplex virus thymidine
kinase gene (HSV TK) in pTK4-CAT. The transcriptional ac-
tivity of these constructs was tested in the IL-2-dependent
human Kit225 cell line (data not shown). The results revealed
that a 250-nucleotide XbaI fragment conferred transcriptional
responsiveness to IL-2 (Fig. 2). A similar induction was ob-
served when this fragment was inserted in reverse orientation
and with a construct containing the 963-nucleotide PvuII/SphI
fragment that includes the XbaI fragment (Fig. 1A). These
experiments identify a novel positive cis-acting regulatory re-
gion in the 59 flanking region of the human IL-2Ra gene, and
they show that this region acts as an IL-2rE like its murine
counterpart. In line with the designation introduced by John et
al. (26), we call this element PRRIII. It does not have any
enhancer activity in Jurkat cells, nor does it confer responsive-
ness to PMA plus ionomycin in these cells (data not shown).
Constitutive and inducible factors bind to PRRIII elements
in vitro. Factors binding to PRRIII were identified by EMSAs
with whole-cell extracts from unstimulated and IL-2-stimu-
lated Kit225 cells and different oligonucleotide probes contain-
ing the putative GAS, EBS, and GATA elements. Since among
these three putative regulatory elements, only the GAS sites
are known to bind IL-2-induced transcription factors (4, 19,
73), we investigated the ability of the GAS-containing probes
to bind Stat proteins, a transcription factor family directly
involved in IL-2 signal transduction. One constitutive (C1) and
two IL-2-induced (C2 and C3) DNA-protein complexes were
identified with the human GASd/EBSd probe (Fig. 3A, lanes 1
to 4). C2 and C3 were detected as early as 5 min after IL-2
addition and persisted up to 30 min. In contrast, no inducible
complex was revealed with the GASp/GATA probe (Fig. 3A,
lanes 5 to 8). As previously described (4), the FcgRI-GAS
probe revealed only two inducible complexes (Fig. 3A, lanes 9
to 12).
To characterize the proteins forming complexes with the
GASd/EBSd probe, we tested the effect of competitors for Stat
and Ets proteins (Fig. 3B). Competition with an excess of
FIG. 2. Functional analysis of the human IL-2rE segment. Kit225 T cells
were starved for 20 h and transfected with various constructions containing the
putative human IL-2rE. The plasmid pCMV-CAT was used to control the phys-
iological state of the cell after IL-2 starvation and IL-2 stimulation. pCMV-CAT
was strongly expressed and not affected by IL-2 stimulation (data not shown). To
control IL-2 induction, we used the plasmid GRR3, which contains three copies
of the FcgRI GAS site. Expression of this plasmid was increased 10- to 20-fold
by IL-2 (data not shown). pTK4, HSV TK minimal promoter CAT construct;
pTK4/250 (59339), 250-nucleotide XbaI fragment (nucleotides24260 to24010)
inserted upstream of HSV TK promoter into pTK4 in its natural orientation;
pTK4/250 (39359), 250-nucleotide XbaI fragment inserted in the reverse orien-
tation into pTK4; pTK4/963 (59339), PvuII/SphI fragment (nucleotides24473 to
23510) inserted into pTK4. The data presented are the means of four indepen-
dent determinations. The error bars represent standard deviations of the mean.
FIG. 3. In vitro complexes formed by GASd/EBSd, GASp/GATA, and
FcgRI-GAS sites, detected by EMSA. (A) IL-2-deprived Kit225 cells were stim-
ulated with IL-2 and harvested at the times indicated at the top of each lane.
Then, 8 ml of whole-cell extracts was incubated with 32P-labeled probes (5 3 104
cpm per reaction). The DNA-protein complexes are analyzed in nondenaturing
acrylamide gels and revealed by autoradiography. (B) Identification of the spe-
cific DNA-protein complexes by competition experiments. Whole-cell extracts
from Kit225 cells, untreated (lane 1) or stimulated for 15 min with IL-2 (lanes 2
to 7), were incubated with the IL-2Ra-GASd/EBSd probe by using Stat-binding
conditions. Competitions were performed with a 1003 excess of the following
unlabeled competitors: wild-type IL-2Ra-GASd/EBSd (lane 3, wt); IL-2Ra-
m1GASd (GASd mut, mutated in the GASd site, lane 4), or IL-2Ra-mEBSd
(EBS mut, mutated in the EBSd site, lane 5). Competition with IL-2Ra-
m2GASd gave the same result as that obtained with IL-2Ra-m1GASd (data not
shown). To address the putative involvement of Ets-related proteins in the
complexes revealed by the GASd/EBSd probes, competition with a 1003 excess
of a high-affinity EBS binding site (EBSa, lane 6) or with a nonbinding mutant
(EBSz, lane 7) was performed.
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unlabeled wild-type GASd/EBSd abolished both inducible
complexes (C2 and C3) but hardly affected the constitutive
complex (C1) (Fig. 3B, lane 3). In contrast, two mutant GASd/
EBSd oligonucleotides, in which the GAS but not the EBS
motif was disrupted, had no effect on C2 and C3 but almost
abolished C1 (Fig. 3B, lane 4 and data not shown). The oligo-
nucleotide containing an intact GAS and a disrupted EBS
motif had the same effect as the wild-type probe (Fig. 3B, lane
5). C2 and C3 were efficiently competed by a 1003 excess of
unlabeled FcgRI oligonucleotide (data not shown). A 1003
excess of the EBSa oligonucleotide completely abolished C1
without affecting the inducible C2 and C3 complexes (Fig. 3B,
lane 6). The mutant EBSz competitor had no effect on any of
the complexes (Fig. 3B, lane 7). Together our results show that
the IL-2-induced C2 and C3 complexes are due to the GAS
consensus sequence present within the human GASd/EBSd
element while the constitutive C1 complex depends on the
EBSd motif. The finding that the EBSa oligonucleotide con-
taining a high-affinity Ets-binding site was able to compete for
the formation of the C1 much more efficiently than the GASd/
EBSd oligonucleotide itself suggests that the GASd/EBSd is a
low-affinity binding site for Ets proteins.
Identification of the constitutive and IL-2-induced proteins
binding to the human GASd/EBSd element. Since IL-2 has
been shown to activate Stat5 in T lymphocytes, we hypothe-
sized that the inducible complexes present in IL-2-treated
Kit225 cells contain Stat5-related proteins. Supershift experi-
ments were performed with two antisera recognizing Stat5.
Addition of anti-sheep MGF/Stat5a (17), a serum that recog-
nizes preferentially Stat5a in supershift assays (16a), to binding
reactions with Kit225 extracts and the GASd/EBSd probe (Fig.
4A, lane 4) did not result in a clear supershift of any of the
specific complexes, while the same antiserum efficiently super-
shifted the complexes formed by cytoplasmic extracts of IL-3-
stimulated Ba/F3 and the GASd/EBSd probe (data not
shown). In contrast, the anti-Stat5 serum C-17, which recog-
nizes both Stat5a and b, supershifted almost completely the
two inducible complexes (Fig. 4A, lane 5).
To characterize the EBS-binding proteins in the C1 com-
plex, supershift experiments with unstimulated whole-cell ex-
tracts from Kit225 and commercial Elf-1-, Ets-1/2-, or Stat3-
specific antisera were performed (Fig. 4B). A partial but
reproducible supershift with anti-Elf-1 serum was observed
(Fig. 4B, lane 2), whereas the commercially available Ets-1/2
and Stat3 antisera had no effect (Fig. 4B, lanes 3 and 4). This
suggested that at least part of the C1 complexes contained
Elf-1. Additional supershift experiments with different antisera
directed against Ets-1/2 (#8), Fli-1 (#61), or Tel (#69) (2, 55),
showed that the anti-Ets1/2 and -Fli-1 reagents partially super-
shifted complex C1 (Fig. 4B, lanes 6 and 7), whereas the
anti-Tel antibodies had no detectable effect (Fig. 4B, lane 8).
An anti-Elf-1 monoclonal antibody (81) gave the same pattern
as the commercial anti-Elf-1 polyclonal serum presented in
Fig. 4B (data not shown). Thus, among the Ets family members
tested, Elf-1, Ets-1, and/or Ets-2 and Fli-1 may all contribute to
the formation of complex C1.
As an alternative method to identify the Stat5 and Ets pro-
teins binding to the GASd/EBSd motif, we used biotinylated
oligonucleotide probes to affinity purify proteins from Kit225
and PBMC whole-cell extracts. The proteins bound to the
GASd/EBSd or the FcgRI oligonucleotide were Western blot-
ted and analyzed with various Stat5- and Ets-specific antisera.
These assays revealed that Elf-1 bound to the GASd/EBSd
probe but not the FcgRI oligonucleotide (Fig. 5C, compare
lanes 1 to 3 and lanes 4 to 6). Elf-1 binding was constitutive and
unaffected by IL-2. The anti-Ets-1/2, -Fli-1, and -Tel sera
showed no specific reaction with any proteins on the same blots
(data not shown). Together with the observation that only a
small fraction of complex C1 was supershifted by the anti-Ets-
1/2 and anti-Fli-1 sera, this suggests that Ets-1 and/or -2 and
Fli-1 only make a minor contribution to the formation of C1.
As expected IL-2 induced Stat5b bound to the GASd/EBSd
probe, but we failed to detect Stat5a proteins in Kit225 cell
extracts (data not shown). To determine if this result was due
to an unexpected difference between the binding specificities
of Stat5a and b or a particularly of Kit225 cells, the experiment
was repeated with whole-cell extracts from IL-2-stimulated
PHA blasts. IL-2 stimulation induced the specific binding of
both Stat5a and Stat5b proteins to the GASd/EBSd and the
FcgRI oligonucleotide (Fig. 5A and B).
Together these experiments demonstrate that both Stat5a
and b proteins can bind the GASd site of the human PRRIII
and that the IL-2-induced C2 and C3 complexes in Kit225 cell
extracts contain Stat5b proteins. Our observations also show
that Elf-1 can bind to the GASd/EBSd site and confirm its
presence in the constitutive complex C1.
IL-2 stimulation of Kit225 T cells and mitogenic stimulation
of human primary T cells result in the in vivo occupancy of the
GASd/EBSd site within the PRRIII. Changes in the pattern of
in vivo protein-DNA interactions in the PRRIII that correlate
with activation of the IL-2Ra locus were analyzed by ligation-
mediated PCR footprint assays. Living T cells were treated
with DMS, which methylates G residues in the major groove of
DNA and to some extent A residues in the minor groove (40).
DNA-binding proteins can protect nucleotides in the binding
site from being, or make bases in or around the binding site,
hypersensitive to methylation. Kit225 cells, exponentially grow-
ing or IL-2 starved for 48 h, were treated with DMS and
harvested. Their DNA was isolated and used for LM-PCR
footprinting. The most striking difference between the two cell
populations was the disappearance, upon IL-2 starvation, of
the protection of the G residue at position 24176 within
GASd/EBSd on the coding strand (Fig. 6A, compare lanes 2
and 3). Note that of the two G residues24175 and24176, only
the latter appears to be methylated by DMS. This is true also
for in vitro methylation of naked DNA. At present we have no
explanation of this phenomenon. Intriguingly, a similar insen-
sitivity to methylation has been observed for the G residue in
the mouse gene that is homologous to residue 24175. IL-2-
dependent protection of G-4176 correlates with the presence
of active Stat5b in IL-2-stimulated but not in IL-2-deprived
Kit225 cells. On the noncoding strand (Fig. 6B), we observed
constitutive protection of G residues 24182 and 24179. This
may reflect in vivo occupation of the GASd/EBSd site by the
constitutively active ETS proteins revealed in the EMSA ex-
periments. In addition, G residue 24159 in the GASp/GATA
site was also protected in both IL-2-starved and IL-2-induced
Kit225 cells, as expected from the characterization of consti-
tutive DNA-protein complexes by EMSA (data not shown). To
determine if these differences could be directly correlated with
Stat5 activation by IL-2, the same experiment was repeated
with cells treated for different times with IL-2. As shown in Fig.
6C, partial protection of the G residue at position 24176 was
observed as soon as 30 min after IL-2 addition.
To confirm the physiological relevance of these observa-
tions, LM-PCR genomic footprint experiments were per-
formed with primary human T cells harvested after different
times of stimulation with a combination of monoclonal anti-
bodies against CD2 and CD28. As illustrated in Fig. 6D, this
strong mitogenic stimulus, which triggers long-term IL-2-de-
pendent activation of resting T lymphocytes (49), induced pro-
tection of G-4176 in the GASd/EBSd site. Protection persisted
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up to 96 h of stimulation. Constitutive occupancy of the site
was also observed on the noncoding strand (data not shown).
The GASd/EBSd element is essential for IL-2 inducibility
and Stat5 can transactivate the PRRIII element whereas Elf-1
can serve as a repressor in Kit225 cells. To test the importance
of the overlapping nuclear factor binding sites in the GASd/
EBSd element for IL-2 responsiveness of the PRRIII en-
hancer, we compared the response of pTK4-CAT/250, contain-
ing the 250-nucleotide XbaI fragment that includes PRRIII,
with that of two mutants. In one of these, the GASd element
was disrupted (5) while the other contained a mutation in the
overlapping EBS motif (Fig. 7A). The mutant PRRIII frag-
ments were subcloned into the CAT expression vector with the
minimal HSV TK promoter. These constructs as well as the
pTK4 vector were tested for enhancer activity by transient
transfection into Kit225 cells that had been deprived of IL-2
for 20 h. After transfection cells were cultured in the absence
or in the presence of IL-2 for 16 h. The results (Fig. 7B) show
that disruption of the GASd site abolished IL-2 inducibility,
strongly suggesting a role for Stat5b in the IL-2 response. On
the other hand, the EBSd mutation significantly increased
basal CAT activity. Expression of this plasmid after IL-2 stim-
ulation was close to that of the wild-type construct, but induc-
tion by IL-2 was only marginal. These results suggest that the
protein binding constitutively to the EBSd site may act as a
repressor. IL-2 stimulation may relieve repression through the
binding of Stat5 to the overlapping GAS site. This model is
consistent with all the data so far presented in this paper.
To obtain more direct evidence for a role of Stat5 and Elf-1
as positive and negative regulators of PRRIII enhancer activ-
FIG. 4. Characterization of the factors binding to GASd/EBSd. (A) Radiolabeled IL-2Ra-GASd/EBSd probe was incubated with whole-cell extracts from
IL-2-deprived (lane 1) or IL-2-stimulated (30 min, lanes 2 to 5) Kit225 cells for 30 min at room temperature, without (lanes 2 and 3) or in the presence of antibodies
directed against Stat5a (lane 4) or both Stat5a and b (lane 5) proteins. Anti-MGF/Stat5a serum had no detectable effect (lane 4) when compared with preimmune serum
(lane 3). Anti-Stat5 serum C-17, which recognizes Stat5a and b proteins, supershifted both inducible complexes (lane 5). (B) To test the involvement of Ets proteins
in the formation of the constitutive complex C1, EMSAs were performed with the 32P-labeled IL-2Ra-GASd/EBSd probe and whole-cell extracts from IL-2 deprived
(lanes 1 and 5) Kit225 cells without (lanes 1 and 5) or in the presence of antibodies directed against different Ets proteins. The following antisera were used: anti-Elf-1
(Santa Cruz Biotechnology, lane 2), anti-Ets1/2 (Santa Cruz Biotechnology, lane 3), anti-Stat3 (UBI, lane 4), anti-Ets1/2 #8 (lane 6), anti-Fli-1 #61 (lane 7), and
anti-Tel #69 (lane 8). The constitutive complex was partially supershifted with the anti-Elf-1 (lane 2), the anti-Ets1/2 #8 (lane 6) and the anti-Fli-1 #61 (lane 7). Filled
arrowheads, position of the specific protein-DNA complexes; open arrowheads, position of the complexes supershifted by the specific antisera. Stars indicate the
positions of complexes due to nonspecific DNA-binding activities (not competed by the addition of unlabeled GASd/EBSd oligonucleotide) in the sera.
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ity, we transfected Kit225 cells with expression vectors for
these proteins, together with the CAT reporter plasmid driven
by the human IL-2rE or with the control vector pTK4. As
shown in Fig. 7C, neither Stat5b nor Elf-1 affected the IL-2
nonresponsiveness of pTK4. Cotransfection with the Stat5b
vector increased both constitutive and IL-2-induced expression
of the PRRIII-driven plasmid pTK4/250, resulting in no sig-
nificant change of its IL-2 response. When increasing amounts
of the Elf-1 vector were included, expression of pTK4/250 in
IL-2-treated cells gradually decreased without any significant
effect on its constitutive expression. The net result was a vir-
tually complete suppression of IL-2 responsiveness, consistent
with a negative role of Elf-1 in PRIII regulation.
Altogether these results strongly support a direct involve-
ment of Stat5 in the IL-2-dependent activation of the human
IL-2Ra gene and indicate that Elf-1 may serve to reduce the
constitutive expression of the human IL-2Ra gene in non-
stimulated T lymphocytes.
DISCUSSION
The a chain of the IL-2R is required for the formation of
high-affinity ligand binding sites. The finding that its expression
is correlated with the capacity of T lymphocytes to proliferate
in response to IL-2 suggested that regulation of IL-2Ra con-
trols, at least in part, IL-2 responsiveness. This was validated by
the observation that T cells of transgenic mice constitutively
expressing the human IL-2Ra gene can respond to IL-2 with-
out antigen stimulation (47). While antigen is the primary
stimulus inducing IL-2Ra transcription, IL-2 itself is required
for maximal and prolonged expression (65 and references
therein). Although it has previously been shown that IL-2
increases transcription of both the human and the mouse IL-
2Ra gene (11, 54), the molecular basis for the IL-2 respon-
siveness of the IL-2Ra gene has not yet been elucidated. Sig-
naling by the IL-2R is mediated by ligand-induced association
of the cytoplasmic domains of its IL-2Rb and gc components
(45, 46). IL-2R do not possess intrinsic kinase activity, but IL-2
binding stimulates the activity of members of both the Src
family of tyrosine kinases (Lck, Fyn, and Lyn) and, as shown
more recently, members of the Jak family (Jak1 and Jak3) (27,
42, 69, 80). In this report, we describe the identification and
characterization of a positive regulatory region (PRRIII) in the
distal 59-flanking region of the human IL-2Ra gene which
possesses an IL-2-dependent enhancer activity. The strong
similarities between the sequences of the human PRRIII and
the IL-2-responsive element in the mouse IL-2Ra gene (90%
identity) and between their cis-acting activities leave no doubt
that these two elements are homologs even though PRRIII is
much more distal (24.1 kb) than its mouse counterpart (21.3
kb) (Fig. 1). The highly homologous proximal regions are sep-
arated from the PRRIII by segments with no detectable simi-
larity which, in the human gene, contain repetitive elements
(unpublished results). This suggests that the human PRRIII
has been separated from the promoter proximal region by one
or more insertions after the split between the evolutionary
branches leading to Mus and Homo.
The results described in this paper lend strong support to the
hypothesis that Stat5 plays a principal role in controlling
PPRIII activity. PRRIII contains a site, GASd (TTCTAGGA
A), which binds in vitro Stat5a and Stat5b proteins that are
activated by IL-2 and is occupied in the chromatin of IL-2-
stimulated T lymphocytes. To our knowledge, GASd is the first
IL-2-responsive enhancer/promoter element characterized
within its physiological context by in vivo footprinting. Nucle-
otide substitutions disrupting the GAS consensus in the GASd/
EBSd site abolish the IL-2-induced enhancer activity of
PPRIII. This is in agreement with effects of point mutations in
the mouse IL-2rE (65).
In vivo genomic footprint analysis demonstrated that occu-
pation of the GASd/EBSd site was induced in Kit225 cells by
IL-2 and in human primary T lymphocytes by a combination of
CD2 and CD28 antibodies. The latter stimulation mimics an-
tigen-mediated activation and triggers potent IL-2-dependent
proliferation (49). We have recently shown that activation of
resting T cells with anti-CD2 and -CD28 antibodies induces a
nearly immediate occupancy of the kB site in the promoter
proximal region of the IL-2Ra gene (1). This contrasts with the
delayed modification of the distal GASd/EBSd element (de-
tectable only after 18 to 24 h of mitogenic stimulation of
resting T cells; data not shown). These observations lend fur-
ther support to a previously proposed two-stage model of the
stimulation of IL-2Ra gene expression in T lymphocytes (65),
according to which antigen induces a first wave of transcription
via promoter proximal elements while IL-2 is responsible for a
secondary amplification mediated by the IL-2rE described
here for the human gene. Our results show that the IL-2-
inducible enhancer activity of PRRIII is independent of the
promoter proximal elements mediating antigen-triggered tran-
scription. The same is true for the mouse IL-2rE (65).
The human IL-2Ra GASd element overlaps with an ETS
binding site (EBS) and is identical with the GAS site of the
bovine b-casein promoter. This site has previously been shown
to form a single inducible complex identified as MGF/Stat5a
with extracts from different nonlymphoid cell lines stimulated
with thrombopoietin, prolactin, growth hormone, or granulo-
FIG. 5. Identification, by DNA affinity purification, of the proteins in normal
human T cells that bind to the GASd/EBSd and FcgRI sites. Oligoprecipitations
of FcgRI-GAS- and GASd/EBSd-bound proteins with PBMC were activated
with PHA for 3 days and then arrested by culturing them in medium without
stimulation. These cells were then cultured for 30 min without (lanes 1 and 4) or
with (lanes 2 and 3 and 5 and 6) IL-2, and whole-cell extracts were prepared.
Proteins binding to the biotinylated oligonucleotides indicated at the top of the
figure were isolated, subjected to SDS-PAGE, and blotted on membranes.
Bound proteins were identified by Western blotting with antisera specific for the
proteins indicated on the right side of the panels (see Materials and Methods).
Where indicated (lanes 3 and 6) a 1003 excess of nonbiotinylated wild-type
GASd/EBSd probe was added to the binding reaction.
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cyte-macrophage colony-stimulating factor (17, 50, 73). In con-
trast, we found that extracts from T lymphocytes form one
constitutive and two IL-2-inducible complexes with a GASd/
EBSd probe. The constitutive complex contains the lympho-
cyte-specific Ets family member, Elf-1, as well as some Ets-1
and/or 2 and Fli-1, whereas the IL-2-inducible complexes from
normal IL-2-stimulated T cells contain Stat5a and Stat5b pro-
teins. Disruption of the EBSd consensus leads to an increase in
basal but not in IL-2-induced PPRIII enhancer activity in T
lymphocytes. This suggests that EBSd may bind a protein that
has a negative effect on enhancer activity and that Stat5 may
act, in part, by competing with this negative regulator. In this
connection it is interesting that Ets-1 can act as a negative
regulator of IL-2 gene expression (57). The constitutive in vivo
protection of nucleotides in the GASd/EBSd site in chromatin
of both IL-2-starved Kit225 or primary resting T cells is con-
sistent with an occupation of this site by a negative regulator.
Elf-1, the protein that clearly was identified in the constitutive
complex formed with GASd/EBSd probe, is involved in the
regulation of the expression of several T-cell specific genes
including IL-2 and IL-2Ra (26, 70), but it has not been de-
scribed as a negative regulator. However, the experiments
showing that cotransfection with increasing amounts of Elf-1
expression vector can abolish the Stat5-dependent IL-2 re-
sponsiveness of the human IL-2rE TK CAT reporter gene
support the model according to which Elf-1 is required to
repress constitutive expression of the IL-2Ra gene in nonac-
tivated T lymphocytes. Since neither of the two anti-Elf-1 sera,
nor any of the tested Ets antisera, completely abrogated or
supershifted the constitutive GASd/EBSd-specific complex, it
is very possible that other members of the Ets family or EBS
binding proteins are implicated in the regulation of IL-2Ra
expression. The competition experiments show that the affinity
of the EBSd motif for the constitutive EMSA complexes is
considerably lower than that of a consensus binding site for Ets
proteins. This suggests that EBSd may provide yet another
example of a weak Elf-1 binding site that is important for the
regulation of a lymphocyte-specific gene (25).
FIG. 7. Functional analysis of the human IL-2Ra GASd/EBSd motif. (A) Nucleotide substitutions introduced into the pTK4/250.59 construct containing the human
IL-2rE (PRIII) (Fig. 2). The overlapping Stat and Ets transcription factor consensus sites are underlined. Substituted nucleotides are in boldface. (B) Expression of
normal and mutated enhancer constructs in the Kit225 T-cell line in the absence or presence of IL-2. Transfections were analyzed and controlled as described in Fig.
2. The data presented are means of at least three independent determinations. The error bars represent standard deviations of the mean. (C) Elf-1 can serve as a
repressor of Stat5-mediated activation of IL-2Ra gene transcription. Kit225 cells were cotransfected with the wild-type pTK4/250.59 CAT plasmid (20 mg) and, where
indicated, with expression vectors for Stat5b (2.5 mg) and Elf-1 (0.5 to 2.5 mg). The data are given as means and standard deviations of at least four independent
experiments.
FIG. 6. In vivo footprinting analysis of the IL-2rE within the human IL-2Ra gene. (A and B) DMS/LM-PCR was performed with in vitro methylated DNA (lane
1 and 4) or DNA from Kit225 cells stimulated for 24 h with IL-2 (lane 2) or IL-2-starved for 48 h (lane 3). (A) Coding strand. (B) Noncoding strand. The G-ladder
shown in lane 4 is a duplicate of lane 1. (C) Time course of the appearance of protection of the G residue at position 24176 in the coding strand. Kit225 cells that
have been starved for IL-2 for 48 h were stimulated with IL-2 for the indicated times and used for in vivo footprinting. Lane 1: in vitro methylated DNA. (D)
DMS/LM-PCR analysis of the coding strand of the PRIII enhancer in chromatin of normal human T cells: G ladder from naked DNA (lane 1), in vivo methylated DNA
from unstimulated cells (lane 2) or from cells stimulated with a mixture of anti-CD2 and -CD28 antibodies for the indicated periods. The autoradiograms presented
are representative of at least four independent experiments. To account for the random variation of counts per residue, the relative intensities of the bands were
compared by densitometric analysis using a BioImage analyzer. Filled arrowheads on the right side of the panels A, C, and D indicate the position of an invariant G
residue at position 24172, and the open arrowheads mark the position of the protected G residue 24176 within the GASd/EBSd element on the coding strand. On
the right side of panel B, the filled arrowheads correspond to the positions of the constitutively protected G residues 24179 and 24182 within the GASd/EBSd site,
and 24159 within the GASp/GATA site on the noncoding strand.
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Ets proteins appear to control transcription by associating
with other regulators of gene expression (3, 9, 12, 20, 26, 75).
This suggests that regulation through the GASd/EBSd element
may depend on a direct interaction between IL-2-induced
Stat5 and the Ets proteins binding to this element. Although
we so far have failed to find any evidence for such an interac-
tion, this possibility needs to be explored further. Interestingly,
the mouse homolog of the human GASd/EBSd site does not
contain an EBS consensus motif. This may be a reflection of
differences between the mechanisms that regulate the mouse
and the human IL-2Ra gene. A discrepancy between these
species has already been observed for the cis-regulatory ele-
ments in promoter proximal region. Cooperative interaction
between NF-kB and SRF, binding to adjacent sites, appears to
play a major role in the activation of the human IL-2Ra gene
in response to anti-CD2 plus anti-CD28 (1, 33, 52), but the
mouse gene does not contain an SRE consensus motif in or
near the kB site conserved in both species (65). Alternatively
the difference between the mouse and human GASd sites may
indicate that the protein that mediates the function of the
human EBSd site is different from the known ETS family
factors.
Regardless of possible species differences, the work de-
scribed here substantially extends previous studies indicating
that transcriptional regulation of the IL-2Ra gene in both
species depends on temporally and spatially coordinated inter-
actions between multiple regulatory proteins. These interac-
tions serve to integrate the signals from the various membrane
receptors that control the efficient and accurate expression of
a gene that is a key regulator of immune responses (1, 26, 65).
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